FIXX Homology Medicines Inc.

Homology Medicines is an US based genetic medicines company. It is dedicated towards translating proprietary, cutting-edge gene editing and gene therapy technology into cures for patients with rare diseases.

$1.55  -0.10 (-6.06%)
As of 05/20/2022 16:00:01 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/28/2018
Outstanding shares:  57,385,578
Average volume:  383,885
Market cap:   $94,686,204
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BFMMJ23
Valuation   (See tab for details)
PE ratio:   -34.40
PB ratio:   0.33
PS ratio:   59.03
Return on equity:   -0.97%
Net income %:   -161.22%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy